Drug Trial Radar · NCT00251719
Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis
Last checked: Nov 20, 2026Latest source record: Feb 3, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,054
Actual
Start
Dec 2005
Primary completion
Jan 2007
Study completion Jan 2007
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Nov 10, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a study to assess the efficacy and safety of 8 weeks of treatment with Dexlansoprazole modified release (MR)(60 mg daily and 90 mg daily) compared to Lansoprazole (30 mg daily) in healing subjects with endoscopically proven erosive esophagitis.
Conditions
- Esophagitis, Reflux
- Esophagitis, Peptic
Interventions
Dexlansoprazole MRDrug
Dexlansoprazole MR 60 mg, capsules, orally, once daily (QD) for up to 8 weeks.
Dexlansoprazole MRDrug
Dexlansoprazole MR 90 mg, capsules, orally, once daily for up to 8 weeks.
LansoprazoleDrug
Lansoprazole 30 mg, capsules, orally, once daily for up to 8 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Subjects With Complete Healing of Erosive Esophagitis by Week 8 as Assessed by Endoscopy - Crude Rate Analysis.Time frame: 8 Weeks
- Percentage of Subjects With Complete Healing of Erosive Esophagitis by Week 8 as Assessed by Endoscopy - Life Table MethodTime frame: 8 Weeks
Locations
144 sites in 16 countries. Site status is shown where the registry gives one.
Site not named
Anniston, Alabama
Site not named
Hueytown, Alabama
Site not named
Huntsville, Alabama
Site not named
Tallassee, Alabama
Site not named
Tuscaloosa, Alabama
Site not named
Tucson, Arizona
Site not named
Little Rock, Arkansas
Site not named
North Little Rock, Arkansas
Site not named
Azusa, California
Site not named
Carmichael, California
Site not named
Cypress, California
Site not named
Fresno, California
Site not named
Los Angeles, California
Site not named
Modesto, California
Site not named
Newport Beach, California
Site not named
Oakland, California
Site not named
Orange, California
Site not named
San Diego, California
Site not named
Santa Maria, California
Site not named
Littleton, Colorado
Site not named
Longmont, Colorado
Site not named
Wheat Ridge, Colorado
Site not named
Bristol, Connecticut
Site not named
Newark, Delaware
Site not named
Fort Myers, Florida
Site not named
Miami, Florida
Site not named
Naples, Florida
Site not named
New Smyrna Beach, Florida
Site not named
Ocala, Florida
Site not named
Pembroke Pines, Florida
Site not named
Port Orange, Florida
Site not named
Sarasota, Florida
Site not named
St. Petersburg, Florida
Site not named
Zephyrhills, Florida
Site not named
Atlanta, Georgia
Site not named
Boise, Idaho
Site not named
Moline, Illinois
Site not named
North Chicago, Illinois
Site not named
Oak Forest, Illinois
Site not named
Evansville, Indiana
Showing 40 of 144 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.